New perspectives on the management of diabetic peripheral neuropathic pain
暂无分享,去创建一个
[1] Misha-Miroslav Backonja,et al. Classification of patients with pain based on neuropathic pain symptoms: Comparison of an artificial neural network against an established scoring system , 2007, European journal of pain.
[2] D. Goldstein. Duloxetine in the treatment of diabetic peripheral neuropathic pain , 2006 .
[3] R. Meyer,et al. Mechanisms of Neuropathic Pain , 2006, Neuron.
[4] T. Harrison. Faculty Opinions recommendation of Lifestyle intervention for pre-diabetic neuropathy. , 2006 .
[5] W. Cayley. Antidepressants for the treatment of neuropathic pain. , 2006, American family physician.
[6] D. Fishbain,et al. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. , 2006, Mayo Clinic proceedings.
[7] G. Bennett,et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. , 2006, Mayo Clinic proceedings.
[8] J. Donohue,et al. Long-acting beta-agonists role in asthma management. , 2006, The Journal of family practice.
[9] C. Argoff,et al. Rational multidrug therapy in the treatment of neuropathic pain , 2006, Current pain and headache reports.
[10] James Albers,et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. , 2006, Diabetes care.
[11] Smriti Iyengar,et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. , 2006, Journal of palliative medicine.
[12] S. Dogra,et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study , 2005, European journal of pain.
[13] B. Stacey,et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. , 2005, Journal of pain and symptom management.
[14] Smriti Iyengar,et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. , 2005, Pain medicine.
[15] M. Detke,et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.
[16] J. Baillie,et al. Morphine, gabapentin, or their combination for neuropathic pain. , 2005, The New England journal of medicine.
[17] E. Eisenberg,et al. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. , 2005, JAMA.
[18] W. Herman,et al. Underdiagnosis of peripheral neuropathy in type 2 diabetes. , 2005, Diabetes care.
[19] H. Sone,et al. Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.
[20] E. Bosi,et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy , 2005, Diabetologia.
[21] S. Tesfaye,et al. Painful diabetic neuropathy , 2005, Diabetologia.
[22] S. Martin,et al. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation , 2005, Diabetologia.
[23] Bernard Laurent,et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) , 2005, Pain.
[24] Nish Chaturvedi,et al. Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.
[25] R. Poole,et al. Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.
[26] B. Stacey,et al. Neuropathic pain symptoms relative to overall pain rating. , 2004, The journal of pain : official journal of the American Pain Society.
[27] U. Thienel,et al. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials , 2004, Acta neurologica Scandinavica.
[28] T. Nurmikko,et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[29] Mark J. Brown. Textbook of Diabetic Neuropathy , 2004, Annals of Internal Medicine.
[30] M. Rowbotham,et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study , 2004, Pain.
[31] J. Arezzo,et al. Diabetic somatic neuropathies. , 2004, Diabetes care.
[32] K. Murray,et al. Cyclic antidepressants and the risk of sudden cardiac death , 2004, Clinical pharmacology and therapeutics.
[33] P. Low,et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[34] R. Prager,et al. The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects. , 2004, Journal of diabetes and its complications.
[35] J. McArthur,et al. New insights into diabetic polyneuropathy. , 2003, JAMA.
[36] Misha-Miroslav Backonja,et al. Neuropathic Pain Questionnaire—Short Form , 2003, The Clinical journal of pain.
[37] Misha-Miroslav Backonja,et al. Development of a Neuropathic Pain Questionnaire , 2003, The Clinical journal of pain.
[38] N. Harris,et al. Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy , 2003, Diabetologia.
[39] T. Jensen,et al. Venlafaxine versus imipramine in painful polyneuropathy , 2003, Neurology.
[40] R. Portenoy,et al. Controlled-release oxycodone for pain in diabetic neuropathy , 2003, Neurology.
[41] R. Baron,et al. Translation of symptoms and signs into mechanisms in neuropathic pain , 2003, Pain.
[42] S. Tesfaye. Diabetic neuropathy: achieving best practice , 2003 .
[43] T. Jensen,et al. Pain phenomena and possible mechanisms in patients with painful polyneuropathy , 2003, Pain.
[44] F. Gries,et al. Textbook of Diabetic Neuropathy , 2002 .
[45] K. Schmader. Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy , 2002, The Clinical journal of pain.
[46] A. Boulton,et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[47] S. Tesfaye,et al. Measurement of somatic neuropathy for clinical practice and clinical trials , 2001, Current diabetes reports.
[48] J. Farrar,et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale , 2001, PAIN.
[49] A. Rice,et al. Mechanisms of neuropathic pain. , 2001, British journal of anaesthesia.
[50] Stephen P. Hunt,et al. The molecular dynamics of pain control , 2001, Nature Reviews Neuroscience.
[51] H. E. Pérez,et al. Gabapentin therapy for diabetic neuropathic pain. , 2000, The American journal of medicine.
[52] B. Galer,et al. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. , 2000, Diabetes research and clinical practice.
[53] S. Leckband,et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. , 1999, Archives of internal medicine.
[54] D. Fishbain. Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient. , 1999, The Medical clinics of North America.
[55] W. Rand,et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial , 1999, Journal of neurology, neurosurgery, and psychiatry.
[56] A. Beydoun,et al. Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial , 1999 .
[57] S. Benbow,et al. Diabetic peripheral neuropathy and quality of life. , 1998, QJM : monthly journal of the Association of Physicians.
[58] B. Galer,et al. Pain assessment and evaluation of patients who have neuropathic pain. , 1998, Neurologic clinics.
[59] P. Raskin,et al. Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy , 1998, Neurology.
[60] N. Harris,et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis) , 1996, Diabetologia.
[61] E Mervaala,et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[62] D. Sackett,et al. The number needed to treat: a clinically useful measure of treatment effect , 1995, BMJ.
[63] M B Brown,et al. A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.
[64] P. Valensi,et al. Reproducibility of Parameters for Assessment of Diabetic Neuropathy , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[65] K. Brøsen,et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy , 1992, Clinical pharmacology and therapeutics.
[66] R Dubner,et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.
[67] K. Brøsen,et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms , 1990, Pain.
[68] M. Uusitupa,et al. Prevalence of Neuropathy in Newly Diagnosed NIDDM and Nondiabetic Control Subjects , 1989, Diabetes.
[69] J. McCann. Rapid development and progression of proliferative retinopathy after strict diabetic control , 1985, British medical journal.
[70] D. Blumer,et al. Chronic Pain as a Variant of Depressive Disease The Pain‐Prone Disorder , 1982, The Journal of nervous and mental disease.
[71] W. Burke,et al. THE TREATMENT OF TRIGEMINAL NEURALGIA: A CLINICAL TRIAL OF CARBAMAZEPINE (“TEGRETOL”) , 1965, The Medical journal of Australia.
[72] Diabetic peripheral neuropathic pain. Consensus guidelines for treatment. , 2006, The Journal of family practice.
[73] T. Tölle,et al. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. , 2006, Journal of diabetes and its complications.
[74] A. Boulton. Management of Diabetic Peripheral Neuropathy , 2005 .
[75] D. Selvarajah,et al. Morphine, gabapentin, or their combination for neuropathic pain. , 2005, The New England journal of medicine.
[76] N. B. Finnerupa,et al. Algorithm for neuropathic pain treatment: An evidence based proposal , 2005 .
[77] Sharon M. Watanabe. Lamotrigine reduces painful diabetic neuropathy : a randomized , controlled study , 2003 .
[78] D. Kapur. Neuropathic pain and diabetes , 2003, Diabetes/metabolism research and reviews.
[79] S. Tesfaye,et al. Understanding the impact of painful diabetic neuropathy , 2003, Diabetes/metabolism research and reviews.
[80] J. Turner,et al. Chronic pain and depression: does the evidence support a relationship? , 1985, Psychological bulletin.
[81] D. Blumer. The pain-prone disorder: , 1981 .
[82] W. J. Hadden,et al. A Comparison of , 1971 .